BRIEF-Gtx To Present Phase 2 Enobosarm Clinical Trial Results In Stress Urinary Incontinence

* GTX TO PRESENT PHASE 2 ENOBOSARM CLINICAL TRIAL RESULTS IN STRESS URINARY INCONTINENCE AT A PODIUM PRESENTATION AT 2018 AUA ANNUAL MEETING Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.